Naoko Takebe to Sarcoma
This is a "connection" page, showing publications Naoko Takebe has written about Sarcoma.
Connection Strength
0.384
-
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma. Clin Cancer Res. 2022 04 14; 28(8):1586-1594.
Score: 0.195
-
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas. Clin Cancer Res. 2022 01 15; 28(2):279-288.
Score: 0.189